In addition, influenza viruses are known to mutate during replication, leading to drug resistance, and can evolve by reassortment into a strain to which most people are not immune, resulting in a pandemic, or into a strain resistant to existing anti-influenza virus drugs, which may be most prevalent in a seasonal epidemic. To protect against these situations, the development of an anti-influenza virus drug with a novel mechanism of action is needed.